Headache & Migraine
Conference Coverage
Conference News Roundup—American Society of Anesthesiologists
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain in patients who have...
Literature Review
Opioids Are Overprescribed for Migraine
Opiates are overused, and acute analgesics with high-quality evidence may be underused, for the treatment of migraine, according to research...
Conference Coverage
New App Aims to Bring Personalized Headache Medicine One Step Closer
STANFORD, CA—Headache specialists have created a new app intended to support patients with headache pain. Developed by board-certified headache...
Conference Coverage
How to Interpret the Results of Clinical Trials
BOSTON—The interpretation of clinical trial results can stray from the data in many ways. Creating spin (ie, stressing an experimental treatment’s...
Literature Review
Can Today’s Stress Level Predict Tomorrow’s Migraine Attack?
Neurologists and patients may be able to predict migraine attacks using a model based on the level of stress from daily hassles, according to...
Literature Review
Headache May Be Independent of Idiopathic Intracranial Hypertension
Headache in idiopathic intracranial hypertension (IIH) appears to be clinically independent of raised intracranial pressure and may require a...
Conference Coverage
A Migraineur’s Headache Frequency Varies Over Time
BOSTON—Patients with migraine may have greater fluctuation in headache frequency than was previously understood. The rate of transition from...
Conference Coverage
Pooled Analysis Clarifies VNS Efficacy in Cluster Headache
BOSTON—Noninvasive vagal nerve stimulation (VNS) is well tolerated and effectively aborts episodic cluster headache attacks, according to a pooled...
Conference Coverage
Headache Trajectories Differ Five Years After TBI
BOSTON—Over five years after traumatic brain injury (TBI), a relatively large (24% to 30%) group of individuals experience chronic headache pain...
Conference Coverage
CGRP Monoclonal Antibodies May Be Beneficial for Migraine Prevention
BOSTON—A new class of drugs for the prevention of chronic and episodic migraine demonstrated promising results in recent phase II and phase III...